CSIMarket
 


Genethera Inc   (GTHR)
Other Ticker:  
 
 

GTHR's Capital Expenditures Growth by Quarter and Year

Genethera Inc 's Capital Expenditures results by quarter and year




GTHR Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 0.00



GTHR Capital Expenditures third quarter 2021 Y/Y Growth Comment
Genethera Inc in the third quarter 2021 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the third quarter 2021, Genethera Inc achieved the best Capital Expenditures growth in Biotechnology & Pharmaceuticals industry. While Genethera Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the third quarter 2021.




GTHR Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Genethera Inc 's third quarter 2021 Capital Expenditures $ 0.00 millions GTHR's Income Statement
Genethera Inc 's third quarter 2020 Capital Expenditures $ 0.00 millions Quarterly GTHR's Income Statement
New: More GTHR's historic Capital Expenditures Growth >>


GTHR Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Capital Expenditures third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Genethera Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GTHR's III. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GTHR's III. Quarter Q/Q Capital Expenditures Comment


Genethera Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Sep 30 2022 period, Genethera Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Genethera Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Sep 30 2022 period, Genethera Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Genethera Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Biotechnology & Pharmaceuticals Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
GTHR's Capital Expenditures Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for GTHR's Competitors
Capital Expenditures Growth for Genethera Inc 's Suppliers
Capital Expenditures Growth for GTHR's Customers

You may also want to know
GTHR's Annual Growth Rates GTHR's Profitability Ratios GTHR's Asset Turnover Ratio GTHR's Dividend Growth
GTHR's Roe GTHR's Valuation Ratios GTHR's Financial Strength Ratios GTHR's Dividend Payout Ratio
GTHR's Roa GTHR's Inventory Turnover Ratio GTHR's Growth Rates GTHR's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2022
Tela Bio Inc -0.34%$ -0.344 millions
Edwards Lifesciences Corporation-1.32%$ -1.318 millions
Neuroone Medical Technologies Corporation-1.34%$ -1.337 millions
Guardant Health Inc -1.91%$ -1.910 millions
Seagen Inc -2.56%$ -2.556 millions
Addus Homecare Corporation-3.00%$ -2.999 millions
Concert Pharmaceuticals Inc -3.03%$ -3.030 millions
Merck and Co Inc -3.92%$ -3.925 millions
Precision Optics Corporation Inc -3.93%$ -3.925 millions
Nextcure Inc -4.32%$ -4.317 millions
Electromed Inc -5.19%$ -5.185 millions
Sight Sciences Inc -5.23%$ -5.226 millions
Veracyte inc -5.41%$ -5.408 millions
Baxter International Inc -6.15%$ -6.145 millions
Natera inc -7.06%$ -7.057 millions
Sio Gene Therapies Inc -7.14%$ -7.143 millions
Replimune Group Inc -7.48%$ -7.477 millions
Rockwell Medical inc -7.87%$ -7.874 millions
Harvard Bioscience Inc-7.92%$ -7.917 millions
Bristol myers Squibb Company-8.52%$ -8.519 millions
Davita Inc -8.54%$ -8.535 millions
Dentsply Sirona Inc -8.57%$ -8.571 millions
Sunlink Health Systems Inc -9.83%$ -9.827 millions
Moderna Inc -10.10%$ -10.101 millions
Rhythm Pharmaceuticals inc -10.38%$ -10.377 millions
Sarepta Therapeutics Inc -10.93%$ -10.930 millions
West Pharmaceutical Services Inc -11.49%$ -11.485 millions
Recursion Pharmaceuticals Inc -11.78%$ -11.776 millions
Cytek Biosciences Inc -12.08%$ -12.080 millions
Universal Health Services Inc -12.09%$ -12.089 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com